SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25,397 | +5.4% | 712 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $24,101 | +17.0% | 712 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $20,591 | -27.5% | 712 | -19.0% | 0.01% | -20.0% |
| Q1 2022 | $28,409 | +13.4% | 879 | +2.3% | 0.01% | +25.0% |
| Q4 2021 | $25,048 | +33.4% | 859 | +22.0% | 0.01% | +14.3% |
| Q3 2021 | $18,776 | -13.4% | 704 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $21,676 | +17.6% | 704 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $18,431 | +4.1% | 704 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $17,713 | +20.7% | 704 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $14,671 | -12.3% | 704 | 0.0% | 0.01% | -22.2% |
| Q2 2020 | $16,720 | +32.0% | 704 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $12,665 | -27.7% | 704 | -4.7% | 0.01% | -11.1% |
| Q4 2019 | $17,529 | -9.4% | 739 | +5.0% | 0.01% | -18.2% |
| Q3 2019 | $19,346 | -17.0% | 704 | 0.0% | 0.01% | -15.4% |
| Q2 2019 | $23,295 | -5.6% | 704 | 0.0% | 0.01% | -7.1% |
| Q1 2019 | $24,668 | -5.5% | 704 | -10.4% | 0.01% | -17.6% |
| Q4 2018 | $26,111 | -26.3% | 786 | +11.6% | 0.02% | -26.1% |
| Q3 2018 | $35,446 | -15.9% | 704 | 0.0% | 0.02% | -20.7% |
| Q2 2018 | $42,134 | +30.7% | 704 | 0.0% | 0.03% | +26.1% |
| Q1 2018 | $32,243 | +14.9% | 704 | 0.0% | 0.02% | +9.5% |
| Q4 2017 | $28,054 | -0.4% | 704 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $28,160 | -7.2% | 704 | 0.0% | 0.02% | -12.5% |
| Q2 2017 | $30,342 | +37.7% | 704 | 0.0% | 0.02% | +33.3% |
| Q1 2017 | $22,035 | +24.0% | 704 | 0.0% | 0.02% | +12.5% |
| Q4 2016 | $17,776 | +2.1% | 704 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $17,410 | +21.4% | 704 | 0.0% | 0.02% | +14.3% |
| Q2 2016 | $14,340 | +33.6% | 704 | 0.0% | 0.01% | +40.0% |
| Q1 2016 | $10,736 | – | 704 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |